Evidence map›Paper›PMID 22428855›Full record

ReviewCritical reviews in immunology2012

Regulation generation: the suppressive functions of human regulatory T cells.

Wendy A Goodman, Kevin D Cooper, Thomas S McCormick

Open access · greenAbstract readReview
In one paragraph

Review in Critical reviews in immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.The Journal of clinical and aesthetic dermatology · 2016
    Review
  12. Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.Turkish journal of haematology : official journal of Turkish Society of Haematology · 2015
    Article
  13. Article
  14. Translating Treg Therapy in Humanized Mice.Frontiers in immunology · 2015
    Review
  15. Article
  16. Article
  17. Adaptive immunity to fungi.Cold Spring Harbor perspectives in medicine · 2014
    Review
  18. Article
  19. Immunology of psoriasis.Annual review of immunology · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Wendy A GoodmanDepartment of Medicine, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA. wag@po.cwru.edu
Kevin D Cooper
Thomas S McCormick
University Hospitals Case Medical Center · USCase Western Reserve University · US

Funding

Vitamin D endocrine system and Protection Against Skin TumorlgenesisP30AR039750 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 1988 to 2015
$9.1M
Systems Biology CoreP50AR055508 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI BARON, ELMA D · 2007 to 2011
$6.8M
Psoriatic Regulatory T cell DysfunctionR01AR051498 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 2004 to 2014
$3.5M
NIAMS NIH HHS AR-051498NIAMS NIH HHS P30 AR039750NIAMS NIH HHS P30AR39750NIAMS NIH HHS P50AR05508NIAMS NIH HHS P50 AR055508NIAMS NIH HHS R01 AR051498
6 · The paper itself

Abstract

Proper regulation of immune homeostasis is necessary to limit inflammation and prevent autoimmune and chronic inflammatory diseases. Many autoimmune diseases, such as psoriasis, are driven by vicious cycles of activated T cells that are unable to be suppressed by regulatory T cells. Effective suppression of auto-reactive T cells by regulatory T cells (Treg) is critical for the prevention of spontaneous autoimmune disease. Psoriatic Treg cells have been observed to a defect in their capacity to regulate, which clearly contributes to psoriasis pathogenesis. A challenge for translational research is the development of novel therapeutic interventions for autoimmune diseases that will result in durable remissions. Understanding the mechanism(s) of dysregulated T cell responses in autoimmune disease will allow for the development of future therapeutic strategies that may be employed to specifically target pathogenic, proinflammatory cells. Several reports have demonstrated a pathogenic role for Thl and Thl7 cells in psoriasis as well as other autoimmune diseases. Similarly, several laboratories have independently demonstrated functional defects in regulatory T cells isolated from patients with numerous divergent autoimmune diseases. One primary challenge of research in autoimmune diseases is therefore to restore the balance between chronic T cell activation and impairment of Treg suppressor mechanisms. To this end, it is critical to develop an understanding of the many suppressive mechanisms employed by Treg cells in hopes of developing more targeted therapeutic strategies for Treg-mediated autoimmune diseases.

Indexed as

Immune ToleranceAnimalsAutoimmune DiseasesCytokinesHumansReceptors, ImmunologicT-Lymphocytes, RegulatoryCytokinesReceptors, Immunologic

Identifiers

PMID22428855
PMCPMC3413266
OpenAlexW2032118844

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.